Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,492 | 844 | 97.1% |
| Consulting Fee | $250.00 | 1 | 1.5% |
| Education | $126.99 | 4 | 0.7% |
| Travel and Lodging | $115.16 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,238 | 79 | $0 (2024) |
| Boston Scientific Corporation | $1,769 | 83 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,644 | 96 | $0 (2024) |
| Abbott Laboratories | $1,362 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,132 | 65 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,037 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,025 | 63 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $799.22 | 71 | $0 (2024) |
| PFIZER INC. | $756.56 | 55 | $0 (2024) |
| Medtronic, Inc. | $750.10 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,660 | 180 | Boston Scientific Corporation ($477.99) |
| 2023 | $2,289 | 106 | Boehringer Ingelheim Pharmaceuticals, Inc. ($419.69) |
| 2022 | $1,825 | 119 | Novartis Pharmaceuticals Corporation ($245.23) |
| 2021 | $2,074 | 128 | AstraZeneca Pharmaceuticals LP ($312.97) |
| 2020 | $2,479 | 115 | AstraZeneca Pharmaceuticals LP ($625.94) |
| 2019 | $1,294 | 60 | Janssen Pharmaceuticals, Inc ($230.26) |
| 2018 | $1,549 | 70 | BOSTON SCIENTIFIC CORPORATION ($277.63) |
| 2017 | $1,815 | 72 | Janssen Pharmaceuticals, Inc ($378.33) |
All Payment Transactions
850 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $94.59 | General |
| Category: Renal Denervation System | ||||||
| 12/13/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $59.22 | General |
| Category: AVVIGO_IC | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.75 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $1.39 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Directional Atherectomy Devices | ||||||
| 12/03/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.50 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: AVVIGO_IC | ||||||
| 11/25/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: AVVIGO_IC | ||||||
| 11/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Obesity | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.81 | General |
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: Obesity | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 5,643 | 10,271 | $1.2M | $905,363 |
| 2022 | 28 | 5,398 | 9,638 | $1.3M | $931,338 |
| 2021 | 22 | 5,030 | 9,252 | $1.2M | $879,285 |
| 2020 | 31 | 5,788 | 10,111 | $1.3M | $1.0M |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 597 | 598 | $295,999 | $232,110 | 78.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 505 | 2,197 | $185,386 | $144,889 | 78.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 635 | 1,436 | $199,842 | $142,260 | 71.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 607 | 623 | $139,670 | $109,349 | 78.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 319 | 1,276 | $77,886 | $54,741 | 70.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 316 | 319 | $70,422 | $51,491 | 73.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 602 | 605 | $47,513 | $32,440 | 68.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 248 | 281 | $39,323 | $29,696 | 75.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 295 | $29,106 | $20,081 | 69.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 720 | 1,496 | $23,744 | $17,474 | 73.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 277 | 286 | $21,500 | $16,122 | 75.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 75 | 76 | $13,669 | $10,447 | 76.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 22 | $13,485 | $10,145 | 75.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $12,767 | $9,302 | 72.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 44 | 44 | $14,547 | $8,359 | 57.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 36 | 39 | $4,258 | $3,318 | 77.9% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 39 | 41 | $4,337 | $3,144 | 72.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 44 | 53 | $5,244 | $2,908 | 55.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 31 | 31 | $2,933 | $2,204 | 75.2% |
| 75630 | Review by radiologist of abdominal aorta and both leg arteries image | Facility | 2023 | 15 | 17 | $4,093 | $1,329 | 32.5% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Facility | 2023 | 15 | 17 | $1,573 | $1,247 | 79.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 65 | 72 | $972.18 | $747.76 | 76.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $1,459 | $698.10 | 47.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 36 | 39 | $710.58 | $563.55 | 79.3% |
| J1245 | Injection, dipyridamole, per 10 mg | Office | 2023 | 57 | 286 | $258.44 | $202.50 | 78.4% |
About Dr. Hormoz Kianfar, MD
Dr. Hormoz Kianfar, MD is a Internal Medicine healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306008727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hormoz Kianfar, MD has received a total of $16,984 in payments from pharmaceutical and medical device companies, with $3,660 received in 2024. These payments were reported across 850 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($16,492).
As a Medicare-enrolled provider, Kianfar has provided services to 21,859 Medicare beneficiaries, totaling 39,272 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Brick, NJ
- Active Since 06/26/2008
- Last Updated 05/07/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306008727
Products in Payments
- ELIQUIS (Drug) $1,739
- BRILINTA (Drug) $1,213
- JARDIANCE (Drug) $1,078
- LifeVest (Device) $1,037
- XARELTO (Drug) $903.48
- FARXIGA (Drug) $684.89
- ENTRESTO (Drug) $580.69
- Resolute (Device) $563.17
- VERQUVO (Drug) $415.79
- CAMZYOS (Drug) $400.36
- COMET (Device) $380.19
- Repatha (Biological) $364.52
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $326.55
- Confirm Rx (Device) $317.11
- AVVIGO Guidance System (Device) $260.28
- Vascepa (Drug) $228.20
- AVEIR (Device) $216.74
- LEQVIO (Drug) $198.84
- PANTHERIS (Device) $190.56
- SYNERGY (Device) $169.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brick
Aditya Mehra, M.d, M.D
Internal Medicine — Payments: $46,046
Dr. Brian Wolfman, M.d., Msc, M.D., MSC
Internal Medicine — Payments: $25,491
Dr. Michael Sher, Md, MD
Internal Medicine — Payments: $22,183
Dr. Ladan Ilkhani, Md, MD
Internal Medicine — Payments: $14,377
Mrs. Alexandra Greenberg, D.o, D.O
Internal Medicine — Payments: $11,217
Dr. Michael Rothberg, Md, MD
Internal Medicine — Payments: $11,177